Done sou Salè H1B

Akèy › Metiyè › Regulatory Affairs Specialists › Cambridge, MA

Regulatory Affairs Specialists nan Cambridge, MA: Salè H-1B

61 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Cambridge, MA. Salè baz medyàn ofri $123,956; mwatye mitan $90,000–$155,096.

Demann (LCA)61
Salè medyan ofri$123,956
Mwatye salè yo$90,000–$155,096
10yèm–90yèm pousantaj$81,346–$180,339

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$68,000
Nivo II (kalifye)$81,682
Nivo III (eksperyans)$90,000
Nivo IV (plen kompetans)$139,064

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
Takeda Development Center Americas, Inc.15$161,500
Biogen Inc.7$89,024
Voisin Consulting, Inc.3$115,000
ModernaTX, Inc.3$106,974
Shire Human Genetic Therapies Inc.3$152,193
Sanofi US Services Inc.2$114,562
Genzyme Corporation2$106,080
Intellia Therapeutics2$243,350
ONEUS Technologies LLC2$68,234
Jounce Therapeutics, Inc.1$125,000
Magenta Therapeutics, Inc.1$103,878
Emergent BioDefense Operations Lansing LLC1$90,000
Corixa Corporation1$103,875
Corixa Corporation d/b/a GlaxoSmithKline Vaccines1$89,024
TCR2 Therapeutics Inc.1$90,000
Iterative Scopes, Inc.1$80,000
Care Access Research LLC1$90,000
Omega Therapeutics, Inc.1$162,000
Editas Medicine, Inc.1$140,000
Beam Therapeutics, Inc.1$120,000
BlueRock Therapeutics LP1$195,000
Moderna Services, Inc.1$125,715
Vor Biopharma Inc.1$82,500
Pfizer Inc.1$161,000
Takeda Manufacturing USA Inc.1$139,027
Relay Therapeutics, Inc.1$100,000
Pharmaceutical Research Associates, Inc.1$123,956
Blueprint Medicines Corporation1$179,946
Philips North America LLC1$81,682
Simcere Zaiming Inc1$68,000
St. Lucia Healthcare Management Corporation1$83,200

Tit travay

Pwonse H-1B nan Cambridge, MA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).